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1 INTRODUCTION 
1.1 Definition and epidemiology of stroke 
The World Health Organization (WHO) standard definition of stroke is “a focal (or global) 
neurological impairment of sudden onset, and lasting more than 24 hours (unless interrupted by 
surgery or death), and with no apparent nonvascular cause”1. Transient cerebral ischemia or 
stroke events in cases of blood disease or brain tumors and secondary strokes caused by 
trauma were not included by this definition2. 
Stroke was estimated to result in 5.5 million deaths each year worldwide, approximately 10% 
of all deaths. In addition to its being the third leading cause of death, stroke is the major cause 
of disabilities among adult3, 4. Report on the US region indicated that the economic cost of 
stroke reached to billions of dollars in US each year5. Projections to the year 2020 indicate 
that the number of people suffering from stroke will substantially increase each year6. Stroke 
incidence also increases as life expectancy is increasing in most parts of the world. By 2025 
there will be more than 800 million people over 65 years of age in the world7. The majority of 
the stroke burden will be in developing countries, largely due to the adoption of "western" 
lifestyles and their accompanying risk factors - smoking, high-fat diet, and lack of 
exercises7,8.  
Stroke death rates have shown a steady decline since early 1990s9-11. The reason for the 
accelerated decline of stroke mortality is uncertain, but it may have resulted from improved 
antihypertensive therapy, management of risk factors, decrease in stroke incidence or case 
fatality, or some other factors12. It was proposed that a possible explanation of decline of 
death rate that the increased use of neuroimaging over time detected more mild strokes that 
would not have been recognized previously13,14.  
Stroke may result from different causes such as cerebral arterial ischemia, intracerebral 
hemorrhage, subarachnoid hemorrhage or venous sinus thrombosis. If the stroke etiology is 
ischemia, it may be caused by cardiac emboli, arterial thromboemboli, vasculopathies, 
  
5
 
iatrogenic insult and pregnancy, etc. Clinically, more than 80% of all stroke result from 
arterial occlusion15, 16.  
The knowledge of the cerebral vascular anatomy and pathogenesis of ischemic stroke is the 
basis for understanding and studying ischemic stroke; therefore it will be briefly reviewed in 
the following sections.  
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1.2 Basic consideration of ischemic stroke 
1.2.1 Arteries of the brain 
The brain is supplied by a dense network of blood vessels, which transport adequate oxygen 
and nutrients for brain’s normal function. The internal carotid arteries (ICAs) usually split into 
the anterior cerebral artery (ACA) and the middle cerebral artery (MCA), and supply blood to 
the anterior three-fifths of cerebrum, except for parts of the temporal and occipital lobes. The 
vertebrobasilar arteries supply the posterior two-fifths of the cerebrum, part of the cerebellum, 
and the brain stem.  
ACA and its branches supply most of the medial surface of the cerebral cortex (anterior three 
fourths), frontal pole (via cortical branches), and anterior portions of the corpus callosum. Its 
perforating branches (including the recurrent artery of Heubner and Medial Lenticulostriate 
Arteries) supply the anterior limb of the internal capsule, the inferior portions of head of the 
caudate and anterior globus pallidus (figure 1). 
 
1. A. Carotis interna 
2. Äste der A. Cerebri media 
3. A. Cerebri anterior 
4. A. frontobasalis medialis 
5. A. callosomarginalis (A. 
cingulomarginalis) 
6. A. frontopolaris 
7. A. frontalis anteromedialis (A. frontalis 
interna anterior) 
8. A. frontalis mediomedialis (A. frontalis 
interna media) 
9. A. pericallosa 
10. A. frontalis posteromedialis (A. frontalis 
interna posterior) 
11. A. paracentralis 
12. A. precunealis superior (A. parietalis 
interna superior) 
13. A. precunealis inferior (A. parietalis 
interna inferior) 
Fig. 1. ACA of the brain. Adapted from Hans-Joachim Kretschmann and Wolfgang Weinrich 17 
The MCA supplies most of the temporal lobe, anterolateral frontal lobe, and parietal lobe. Its 
perforating branches supply the posterior limb of the internal capsule, part of the head and 
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body of the caudate and globus pallidus. (figure 2). 
1. A. carotis interna 
2. A. cerebri media, orthograd verlaufend 
3. Abgang der A. cerebri anterior 
4. A. frontobasalis lateralis 
5. Aa. Insulares 
6. Aa. Prefrontales 
7. A. sulci precentralis   (A. praerolandica) 
8. A. sulci centralis     (A. rolandica) 
9. A. parietalis anterior 
10. A. parietalis posterior 
11. A. gyri angularis 
12. A. temporooccipitalis  (A. occipitotemporalis) 
13. A. temporalis posterior 
14. A. temporalis intermedia (A. temporalis media) 
15. A. temporalis anterios 
16. A. temporopolaris 
Fig. 2. MCA of the brain. Adapted from Hans-Joachim Kretschmann and Wolfgang Weinrich17 
The two vertebral arteries continue in the basilar artery that splits into arteries supplying the 
posterior fossa and the two posterior cerebral arteries (PCAs). The PCA supplies parts of the 
midbrain, the subthalamic nucleus, the basal nucleus, the thalamus, the mesial inferior temporal 
lobe, and the occipital and occipitoparietal cortices. In addition, the PCAs, via the posterior 
communicating arteries, may become important sources of collateral circulation for the MCA 
territory. (figure 3). 
1. A. vertebralis 
2. Abgang der A. cerebelli inferior posterior 
3. A. basilaris 
4. Abgang der A. cerebelli inferior anterior 
5. Abgang der A. cerebelli superior 
6. A. cerebri posterior 
7. Aa. centrales posteromedialis und 
posterolateralis (Aa. thalamoperforantes 
anteriores und posteriors) 
8. Aa. choroideae posteriors medialis und lateralis 
9. A. occipitalis medialis (A. ocipitalis interna) 
10. A. parietooccipitalis 
11. A. calcarina 
12. A. occipitalis lateralis (A. temporooccipitalis, A. 
occipitotemporalis) 
13. Aa. temporales 
14. A. communicans posterior 
15. A. carotis interna 
 
Fig. 3. Posterior circulation. Adapted from Hans-Joachim Kretschmann and Wolfgang Weinrich 17 
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Anastomoses and collaterals 
During an acute ischemic onset, the occlusion of a large vessel (such as MCA) is rarely 
complete because of not only the incomplete obstruction but also the collateral circulation. 
Common and important anastomoses can occur between (1) external carotid and internal 
carotid via branches of the facial-, angular- and especially the ophthalmic arteries; (2) the 
major intracranial vessels (e.g. PCAs, ICAs and ACAs) via the circle of Willis; (3) muscular 
branches of cervical arteries and the extracranial vertebral or external carotid arteries; (4) 
small cortical branches of ACA, MCA, and PCA, (e.g. the posterior choroidal artery or the 
posterior pericallosal artery) or branches of the major cerebellar arteries.  
Many smaller penetrating brain vessels such as the lenticulostriate branches of MCA that 
supply the basal ganglia and internal capsule, as well as the penetrating branches from vessels 
on the brain surface that supply deep white matter, are terminal arteries. This means that they 
form few if any connections (anastamoses) with other arteries.  When they are occluded, the 
brain regions they supply will therefore become ischemic. 
The occlusion of the MCA or its branches is the most common type of anterior circulation 
infarct, accounting for approximately 90% of infarcts and two thirds of all first strokes18. For 
this reason and for group homogeneity, this work will concentrate on ischemic stroke on MCA 
territory only. 
1.2.2 Pathogenesis of ischemic stroke 
The main mechanisms causing ischemic strokes are: (1) cardiogenic embolism, (2) 
arteriosclerosis causing arterial embolism. Hypotensive ischemia, venous occlusion, 
hemorrhagic stroke and other causes such as vasospasm and arteritis stand out among the 
infrequent causes of stroke, and will not be reviewed here. 
(1) Cardiogenic embolism. Cardiogenic embolic stroke can result from mobilization of an 
embolus in the central circulation from a variety of sources. Besides clot, fibrin, pieces of 
athermanous plaque, materials known to emblaze into the central circulation include fat, air, 
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tumor or metastasis, bacterial clumps, and foreign bodies. Superficial branches of cerebral 
arteries are the most frequent targets of emboli, most emboli lodge in the middle cerebral 
artery distribution. The two most common sources of emboli are the left sided cardiac atrium 
and large arteries. Many embolic strokes become “hemorrhagic” due to reperfusion. 
(2) Arterial thromboembolism. Arteriosclerosis is the most common pathological feature of 
vascular obstruction resulting in arterial thromboembolism stroke. Arteriosclerotic plaques 
can undergo pathological changes such as ulceration, thrombosis, calcification, and 
intra-plaque hemorrhage, which in turn might lead to disruption of endothelium. The 
endothelium disruption might cause further platelet adherence and inflammatory response. 
The plaque gradually narrows the diameter of the artery reducing the flow of blood. Typical 
sites for arterial thromboembolism to migrate from are the arteriosclerotic plaque of the 
carotid bifurcation and the proximal portion of the internal carotid artery. 
The various vascular territories affected in cerebral infarcts usually correlate to the different 
etiologies19. MCA territory infarction is most likely to be caused by emboli. The deep 
penetrating end-arteries of MCA and PCA can be occluded individually leading to lacunar 
infarcts. These lacunar defects are due to local lipohyalinosis induced by hypertension or 
arterial thromboembolism caused by arteriosclerosis and are not further discussed here.  
1.2.3 Pathophysiology of ischemic stroke at macro tissue level 
Perfusion metabolism - coupling and uncoupling20 
Under physiological conditions, a coupling exists between the demand for oxygen and 
glucose by the cells and the regional cerebral perfusion. During cerebral ischemia, the supply 
of blood and therefore the supply of oxygen and glucose are decreased and energy demands 
may not be met. The uncoupling process of the regional cerebral perfusion and metabolism 
has been examined by positron emission tomography (PET) in several animal and human 
studies20. The threshold principle of regional cerebral perfusion and metabolism in ischemia 
are reviewed in the following.   
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Cerebral blood flow (CBF) and ischemic thresholds 
An embolus or a thrombus can occlude a cerebral artery and cause ischemia in the affected 
vascular territory. No matter what the ischemia cause is, they eventually lead to a focal or 
general reduction of perfusion in the brain and reduce supply of oxygen and glucose. 
The normal CBF is approximately 50 to 60 ml/100g/min and varies in different parts of the 
brain in monkey. When the CBF is reduced around 22 ml/100g/min, hypoperfusion appears; 
while when the CBF drops to 8 ml/100g/min irreversible damage occurs21, 22. (Figure 4)  
 
Fig. 4: Diagram of CBF thresholds required for the preservation of function and morphology of brain tissue. 
The development of single cell necrosis and infarction is dependent on the duration of time for which CBF 
is impaired below a certain level. The solid line separates structurally damaged from functionally impaired 
but morphologically intact tissue (the "penumbra"), and the dashed line distinguishes viable from 
functionally impaired tissue. 23 
The viable tissue (i.e. with CBF between 22 and 8 ml/100g/min), in contrary to the core of the 
ischemia (i.e. with CBF <8 ml/100 g/min), was termed “ischemic penumbra” to describe the 
geographic configuration of an ischemic area21. The mild hypoperfusion tissue (i.e. from the 
normal range down to 22 ml/100 g/min) was well tolerated by the tissue and did not induce 
neuronal dysfunction was termed oligemia. In contrast to the penumbra, the oligemic tissue is 
not at risk of infarction under uncomplicated conditions24. In the studies of man, different 
imaging techniques concur very well in suggesting a penumbra threshold around 20 ml/100 
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g/min, and an infarction threshold around 8 ml/100 g/min for stroke duration in the 3-24 h 
interval. Between 22 and 8 ml/100g/min, there was a well-defined “perfusion window of 
opportunity” for tissue salvage24. Figure 5 illustrates the proposed CBF thresholds in man. 
 
Fig. 5. Schematic drawing of the different CBF thresholds in man, based on the literature. a Marchal et al25, 
26 and Furlan et al.27; b Heiss et al28, 29. 
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1.3 Magnetic resonance imaging (MRI) in stroke 
MRI provides excellent anatomic detail; has the ability to differentiate between ischemic and 
infarcted brain tissue; and potentially provides angiographic, spectroscopic, and perfusion 
weighted information of the cerebral vessels and of the tissue bed. MRI also has higher 
sensitivity and specificity than computed tomography (CT) in the detection of other brain 
diseases that can mimic stroke clinically such as cerebral edema, vascular malformations, 
neoplasms, infections, inflammatory diseases, and toxicometabolic disorders30. MRI has the 
added advantage of lack of exposure to ionizing radiation but the disadvantage of higher cost.  
The value of conventional MRI in stroke examination is limited during the hyperacute stage 
(<6 hrs). At acute stage (6-24 hrs after ictus) the tissue ischemia is well developed on 
fast-fluid-attenuated inversion recovery (FLAIR) images and begins to show on T2 wighted 
imaging (T2WI) (hyperintensity) and T1 weighted imaging (T1WI) (hypointensity). After the 
first 24 hours, conventional MRI is most useful since the focus now shifts from identifying 
the presence and extent of infarct and ischemic penumbra to identifying the underlying 
pathophysiology and to provide follow-up data. Edema is generally maximal at 48 to 72 hours 
beyond ictus; mass effect is best appreciated on T1WI; gyriform parenchymal enhancement is 
typically seen approximately 5 to 7 days and might remain for a few weeks during the 
subacute stage; both petechial hemorrhage and frank hematomas may be seen, especially at 24 
to 48 hours after stroke onset; and petechial hemorrhage within infarctions may give rise to a 
"fogging" phenomenon in which hemoglobin degradation products, extravasated proteins, or 
both generate signal changes within infarcted tissue, which mask the infarction on T1WI and 
T2WI. 
In hyperacute stroke, the contribution of functional MRI is important. In the past decade, 
diffusion weighted imaging (DWI) and perfusion weighted imaging (PWI) techniques have 
revolutionized the role of MRI in the evaluation of patients with acute stroke31. DWI provides a 
measure of cell swelling, as the interstitial space is compromised and then the Brownian motion 
of water molecules is shifting from the extra- to the intracellular space due to the failure of the 
Na/K pumps in the absence of O2. PWI is a measure of hemodynamic compromise, as it 
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measures the delay of arrival time at the brain and allows to calculate cerebral blood volume 
(CBV), CBF and other hemodynamic parameters. The combined data from these two 
modalities can delineate the pathophysiological state of ischemia and may provide a practical 
means to rapidly identify the ischemic penumbra in the acute stroke setting32. Thus, MR 
imaging can now fully assess the brain in cases of acute stroke and a full vascular imaging 
protocol is thus usually possible in less than 30 minutes. (Table 1). 
Table 1. MRI findings in acute ischemic changes 
Time MRI finding Etiology 
2-3 min DWI - Reduced ADC Decreased motion of protons 
2-3 min PWI - Reduced CBF, CBV, MTT Decreased CBF 
0-2 hr T2WI - Absent flow void signal Slow flow or occlusion 
0-2 hr T1WI - Arterial enhancement Slow flow 
2-4 hr T1WI - Subtle sulcal effacement Cytotoxic edema 
2-4 hr T1WI - Parenchymal enhancement Incomplete infarction 
8 hr T2WI - Hyperintense signal Vasogenic and cytotoxic edema 
16-24 hr T1WI - Hypointense signal Vasogenic and cytotoxic edema 
5-7 days Parenchymal enhancement Complete infarction 
The specific role of MRI in detecting ischemic stroke is from its three main advantages 
relative to other techniques: (1) Its ability to image not only cerebral perfusion but also the 
status of tissue (diffusion), the patency of the vasculature (MR angiography [MRA]), and the 
anatomical substrate during the same imaging session; (2) The potential for differentiating 
reversibly and irreversibly ischemic tissue by defining the diffusion/perfusion mismatch; (3) 
The rapidity of imaging the entire brain during the perfusion study, rather than a limited 
volume of brain tissue. 
There are, however, limitations of the DWI and PWI that need to be emphasized. (1) The 
absolute values of the parameters are dependent on variety of factors, such as time and spread 
of the injected bolus during the passage of the lung. It is necessary for PWI reconstruction to 
utilize the deconvolution method and requires knowledge of arterial input function (AIF), thus 
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makes the post-processing complex and is dependent on experienced user. Also the 
determination of AIF is dependent on acquisition and bolus injection, it is difficult to make 
the accuracy of the quantification of perfusion imaging; (2) The DWI lesion potentially 
overestimates the volume of the irreversibly ischemic tissue early after the onset of ischemia, 
and the mean transit time (MTT) map appears to overestimate the size of the reversible tissue. 
Hence, the diffusion/perfusion mismatch area might only be an index of the ischemic 
penumbra. (3) Motion artefact is one of the limitations of DWI. DWI is highly sensitive in 
detecting tissue damage in cerebral ischemia, but it is also highly sensitive to macroscopic 
motion either by patient motion or by tissue motion due to cerebro-spinal fluid (CSF) pulsation. 
This problem can be avoided through pulse sequence design and image post-processing 
techniques. For this reason, echo-planar imaging (EPI) is the most frequently used sequence. It 
requires a higher gradient strength specification. 
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1.4 Acute stroke management 
According to European Stroke Initiative (EUSI) recommendation for stroke33, there are 5 
main areas in the treatment of acute stroke:  
(1) General therapy. Treatment of general conditions that need to be stabilized.  
(2) Specific therapy directed against particular aspects of stroke pathogenesis, either 
recanalization of a vessel occlusion or prevention of mechanisms leading to neuronal 
death in the ischemic brain (neuroprotection).  
(3) Prophylaxis and treatment of complications which may be either neurological (such as 
secondary hemorrhage, space-occupying edema or seizures) or medical (such as aspiration, 
infections, decubital ulcers, deep venous thrombosis or pulmonary embolism).  
(4) Early secondary prevention, which is aimed at reducing the incidence of early stroke 
recurrence.  
(5) Early rehabilitation. 
Thrombolytic therapy is among the main specific treatment options34 for stroke. By 
intravenous recombinant tissue plasminogen activator (rt-PA) given within 3 hours after 
onset, it significantly improves outcome. This thrombolytic therapy is suggested to be given 
only if the diagnosis is established since serious complications may occur. Intravenous 
streptokinase has been shown to be associated with an unacceptable risk of hemorrhage and 
associated with death. Aspirin and other therapies such as defibrinogenating enzymes, early 
anticoagulation, hemodilution and neuroprotection has shown improved outcome or reduced 
the mortality after stroke.  
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1.5 Rational and purpose of the current study 
When an acute ischemic stroke patient arrives at a hospital, it is important to obtain timely 
information about the likely outcome and to make a treatment decision. Though it is well 
accepted that infarct size as detected on neuroimaging studies constitutes a strong predictor of 
clinical outcome35, and the severity of the clinical deficit on admission is considered to be the 
major determinant of functional outcome36, 37, however, the recognition of the ischemia in the 
hyperacute stage using both clinical assessment and routine neuroimaging technique implies 
some uncertainties, which in turn makes it difficult to clinically predict an outcome of an 
ischemia that likely to improve or reverse spontaneously from that likely to persist or worsen.  
Among neuroimaging techniques, MRI with its excellent anatomic detail and the ability to 
differentiate between ischemic and infarcted brain tissue; and to provide angiographic, 
perfusion information of the cerebral vessels and tissue bed, is recognized as the major 
technique in stroke evaluation. Soon after DWI being introduced to stroke evaluation, 
research began to focus on the correlation of acute ischemic volume with outcome. There is a 
strong positive correlation of neurologic deficit with volume of the initial DWI lesion, as well 
as with the severity of the initial apparent diffusion coefficient (ADC) abnormality38. 
Combined evaluation of lesion volume at early DWI, the National Institutes of Health Stroke 
Scale (NIHSS) and time from stroke onset to MRI shows that the volume of ischemic brain 
tissue on MRI DWI give the best prediction of stroke outcome39. While DWI provides a 
measure of the ischemic tissue swelling, a PWI provides information about the hemodynamic 
status of brain tissue and detects regions with impaired cerebral perfusion40, 41.  
During the first hours of stroke evolution, regions with abnormal perfusion are typically larger 
than the DWI lesions42, 43. This is referred to as a diffusion/perfusion mismatch, and is often 
associated with large vessel (such as proximal MCA) occlusion. It has been postulated that 
this mismatch region reflects the ischemic penumbra44, i.e., the functionally impaired “tissue 
at risk” surrounding the irreversibly damaged ischemic core (figure 6). 
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Fig. 6. Schematic of the mismatch model for defining the ischemic penumbra. 
Diffusion-weighted imaging abnormality≈Core 
       Perfusion abnormality≈tissue at risk 
Diffusion/Perfusion Mismatch≈Penumbra 
Clinical reports have demonstrated that the impaired perfusion region is typically larger than 
the lesion detected by DWI early after stroke onset, and this diffusion/perfusion mismatch 
volume correlated with growth in DWI lesion volume on follow-up studies45. Derived from 
perfusion MR imaging the hemodynamic parameters (such as CBV, CBF, and MTT) has been 
proved to be useful adding information estimating ischemia stroke46-48. It is might also be 
useful to quantify the perfusion deficit within the diffusion/perfusion mismatch region to 
distinguish the real area at risk for infarction from the oligemic tissue in which blood flow is 
greater than the critical viability threshold. Since both ischemic core and the 
diffusion/perfusion mismatch region may have perfusion abnormalities, correlations of 
perfusion abnormalities with clinical severity and outcome might exist in those two 
corresponding regions. 
The diffusion/perfusion mismatch was recognized as a simple and feasible means to 
identify the ischemic penumbra32. Therefore, we evaluated the hemodynamic 
parameters in both ischemic core and diffusion/perfusion mismatch region in acute 
stroke patients. It was our hypothesis that the hemodynamic parameters, such as rCBF, 
  
18
 
rCBV, MTT, TTP and T0, exhibited correlation with the NIHSS score and the outcome 
measured by modified Rankin scale (MRS). To our knowledge, no previous study 
concerning prediction of outcome of ischemic stroke by MRI derived hemodynamic 
parameters was reported.  
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2 MATERIALS AND METHODS 
2.1 Patients  
All patients who presented to the neurological department of Klinikum Großhadern with 
symptoms of acute stroke between October 2000 and April 2004 were reviewed. 
Approximately 140 patients underwent both DWI and PW imaging. Of these, 62 were imaged 
within 72 hours. 35 acute stroke patients (male:female=20:15, age: 61.3±15.2 years) who met 
the study inclusion and exclusion criteria were then selected on the basis of the following 
criteria.  
The inclusion criteria were as follows:  
(1) Imaging within 72 hours of stroke onset;  
(2) Availability of conventional MRI images and DWI and PWI image data sets;  
(3) Abnormalities shown on both time to peak (TTP) images and the DWI image;  
The exclusion criteria were as follows:  
(1) With any contraindication to MRI scanning as: a) Central nervous system aneurysm 
clips; b) Implanted neural stimulator; c) Implanted cardiac pacemaker or defibrillator; 
d) Cochlear implant; e) Ocular foreign body (e.g. metal shavings); f) Insulin pump; g) 
Metal shrapnel or bullet; h) Any implanted device that is incompatible with MRI.  
(2) Patients with recent ischemic stroke within prior 30 days or rapidly resolving deficit.  
(3) Patients with ischemia at infratentorial region, lacunar ischemia and ischemia at 
thalamus or pons.  
(4) Any intracranial surgery, intraspinal surgery, or serious head trauma (any head injury 
that required hospitalization) within the past 3 months.  
(5) PWI not obtained or uninterpretable.  
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(6) No TTP defect corresponding to acute stroke deficit.  
(7) Remarkable artifact on MRI images which were not workable for further analysis.  
Significant cerebro-vascular risk factors such as arterial hypertension, hypercholesterolemia, 
diabetes mellitus and nicotine were recorded in 27 patients. Patient characteristics (including 
age, sex, clinical symptoms, risk factors, time to scan, occlusion type, patency of the artery in 
MRA, NIHSS scale, means of treatment, MRS outcome score and volume ratio were recorded 
and summarized in table 2.  
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Table 2. Patients’ clinical information 
No. Age Sex Symptoms Risk factor 
Time to 
scan (h) 
Occlusion 
type 
Patency of artery 
in MRA 
NIHSS Treatment MRS Vd/Vp ratio
1 58 F rt hemip  hypercholest., art. hypert 1.7 MCA, lt 0 4 (-) 2 <1/3 
2 68 F aphasia, weakness of rt hand art. hypert 3.4 MCA, lt 0 13 i.v. Lysis 3 <1/3 
3 77 F aphasia, weakness of rt arm art. hypert 14 MCA, lt 0 19 i.a. 6 <1/3 
4 47 F lt hemip none 6 MCA, rt 0 9 (-) 4 <1/3 
5 49 M aphasia hypercholest., art. hypert 4.5 MCA, lt 60 9 i.v. Lysis 4 <1/3 
6 67 M aphasia, rt hemip art. hypert, hypercholest. 2.5 MCA, lt 0 12 i.v.+i.a. 4 <1/3 
7 41 M weakness of lt leg none 2.4 MCA, rt 0 11 i.v. 3 <1/3 
8 26 F hemip rechts,aphasia       nicotine 2.5 MCA, lt 0 19 i.v.+i.a. 2 1/3<ratio<1/2
9 39 M aphasia, weakness of rt hand art. hypert 0.9 MCA, rt (-) 16 i.v.+i.a. 3 <1/3 
10 72 M rt hemip, aphasia DM, art. hypert 4.1 MCA, lt (-) 11 i.a. 3 <1/3 
11 62 M aphasia, lt arm weakness hypercholest., art. hypert 48 MCA, rt 0 14 i.v. 4 1/2<ratio<1
12 73 M aphasia art. hypert 48 MCA, rt 0 4 (-) 2 <1/3 
13 72 M aphasia, weakness of rt side hypercholest., art. hypert 15 MCA, lt 100 7 (-) 0 <1/3 
14 40 F hemip rt, aphasia  hypercholest., art. hypert 1.9 MCA, lt 0 8 i.a. 2 1/2<ratio<1
15 74 M hemip rt, aphasia  hypercholest.  5 MCA, lt 0 12 i.a. 5 <1/3 
16 77 F aphasia, weakness of rt side not available 12 MCA, lt (-) 12 (-) 3 <1/3 
17 78 M aphasia, weakness of rt side diabetes mellitus 18 MCA, lt 100 11 i.v. 4 <1/3 
18 75 M hemip rt, aphasia  not available 72 MCA, lt 20 4 (-) 3 1/2<ratio<1
19 86 F aphasia, righ hemip hypercholest., art. hypert  45 MCA, lt 100 8 (-) 2 1/2<ratio<1
20 56 F rt hemip, aphasia CHD, art. hypert, nicotine 4.6 MCA, lt (-) 9 i.a. 3 <1/3 
21 56 M weakness of lt arm nicotine 7.7 MCA, rt (-) 8 (-) 3 <1/3 
22 40 M hemip rt, aphasia  art. hypert 66 ICA lt 0 16 i.a. 1 <1/3 
23 40 F hemip rt, aphasia none 5 ICA lt 0 13 i.a. 6 <1/3 
24 61 M hemip lt not available 3.9 MCA, rt (-) 12 i.a. 6 <1/3 
25 70 M hemip rt, aphasia not available 5 MCA, lt 0 10 i.v. 3 <1/3 
26 64 F aphasia, weakness of lt side hypercholest., art. hypert, 23.8 MCA, rt (-) 4 (-) 4 <1/3 
27 65 F aphasia art. hypert 5.4 MCA, lt (-) 8 (-) 3 <1/3 
28 73 F hemip lt hypercholest., art. hypert 12 ICA rt (-) 0 (-) 0 <1/3 
29 92 M hemip, lt art. hypert 7 MCA, rt 0 11 (-) 6 <1/3 
30 48 M hemip, lt DM, art. hypert,  22 ICA, rt (-) 12 (-) 4 <1/3 
31 63 M hemip lt, aphasia arrythmia 3 MCA+ICA, lt 0 13 (-) 4 <1/3 
32 61 F hemip lt, Dysarthrie  hypercholest. 3.7 MCA, rt 20 13 (-) 4 <1/3 
33 72 F aphasia art. hypert 5.4 MCA, lt 30 6 i.a. 4 <1/3 
34 46 M hemip lt hypercholest., Adipositas  16 MCA, rt 10 3 (-) 2 <1/3 
35 56 M hemip rt, aphasia  none 5.9 ICA, lt 50 15 (-) 5 <1/3 
Note: rt = right, lt =left, hemip=hemiparesis,  hypercholest = hypercholesterolemia, art. hypert= arterial 
hypertension, DM= Diabetes mellitus, Vd=volume on DWI, Vp =volume on PWI.    (-)= no lysis treatment, 
with secondary stroke prophylaxis; i.a.= intraarterial treatment (anjiojet, clot-retriever, intraarterial lysis)  
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2.2 Neurological assessment  
The NIHSS49, 50 assessment was immediately performed at the patients’ admission by a 
certified and trained neurologist. The NIHSS contains several categories on (1) level of 
consciousness, (2) best visual, (3) best gaze, (4) facial weakness, (5)/(6) motor arm and leg, (7) 
limb ataxia, (8)sensory, (9) best language, (10) dysarthria, and (11) extinction and inattention 
with various level of scores. (Please refer to the detail of NIHSS scale in appendix 1.)  
Functional outcome was measured on the day of hospital discharge according to MRS 
outcome scale51, 52. From scale 0 to 6, the outcome ranges from no symptoms at all to more 
severely disability, and death. (Table 3)  
Table 3: Content of MRS 52 
Scale Outcome 
0 No symptoms at all 
1 No significant disability despite symptoms; able to carry out all usual duties and activities 
2 Slight disability; unable to carry out all previous activities, but able to look after own affairs without assistance 
3 Moderate disability; requiring some help, but able to walk without assistance 
4 Moderately severe disability; unable to walk without assistance and unable to attend to own bodily needs without assistance 
5 Severe disability; bedridden, incontinent and requiring constant nursing care and attention 
6 Dead 
The NIHSS and MRS of all the patients were evaluated by an experienced neurologist. 
All the recruited patients were hospitalized at a dedicated stroke unit (G7B), and received 
hemodilatation, antihypotensive measures and had their body temperature and blood glucose 
level controlled. In case of elevated temperature, up to 3 grams of Paracetamole were given, 
and the glucose level was controlled by insulin. Depending on the individually clinical, 
neurological and neuroradiological situation the patients were also selectively treated by 
intravenous thrombolysis, intraarterial thrombolysis, intraarterial mechanical thrombus 
extraction.  
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2.3 Technical consideration  
Routine MRI sequences and DWI and PWI were employed in our patients study. Since DWI 
and PWI technique is the basis of the study, a general review is necessary. Although diffusion 
weighted imaging and perfusion weighted imaging are distinctly different techniques, they are 
interrelated physiological parameters, and are usually performed during the same imaging 
examination. 
2.3.1 Diffusion weighted imaging (DWI) 
That water molecules are in constant random motion is called diffusion. Water diffusion in the 
intracellular space is much more restricted than in the extracellular space and thus does not 
contribute to imaging. In acute brain ischemia, water shifts from the extra- to the intracellular 
space with subsequent reduction of water motion in the extracellular space. This in turn 
inhibits the dephasing normally present in a DWI image, making this area bright. Thus the 
bright spots in DWI masks areas of acute cell ballooning due to Na/K pump failure53. DWI 
visualizes the motion of ischemia-induced changes in water protons within minutes after an 
insult54, 55.  
DWI offers the unique opportunity to address noninvasively fundamental issues regarding the 
response of the brain tissue to ischemia at different stages. In order to do this, a pair of strong 
gradients pulses symmetrically placed around the 180º refocusing radiofrequency (RF) pulse 
is added to dephase and rephrase static water protons to separate fast and slow moving water 
molecules56. The first gradient dephases the spins, while the second gradient, which is applied 
after a distinct time interval (diffusion time ,) rephases the spins. (Figure 7). 
Since the random molecular motion exists in all tissues, there is a certain loss of phase 
coherence that produces a signal loss in normal tissue. On the contrary, with less water 
movement, less dephasing occurs while the diffusion gradient are resulting in a higher signal 
intensity, as occurs with ischemic cell depolarization55, 57.  
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Fig. 7. DWI utilizes a pair of magnetic field gradient pulses placed symmetrically around the 180º 
refocusing RF pulse to dephase and rephase static water protons. Randomly moving water protons in 
normal brain tissue will experience incomplete spin rephasing resulting in a signal loss. Restricted diffusion 
as occurs with ischemic cell depolarization results in spin rephasing and retained MR signal with 
hyperintensity in DWI (Adapted from Hamann). 
This signal variation depends on two parameters: (1) the tissue parameter, apparent diffusion 
coefficient (ADC), reflecting the mobility of the water molecules. ADC is a quantitative value, 
which can show the amount of water movement. A low ADC value indicates less water 
movement. (2) The sequence parameters, b-value58, reflecting the degree of 
diffusion-weighting (Figure 8). Quotation 1 reflect the relation among the signal variation, 
ADC and b-value: 
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Fig. 8. Within an ischemic lesion where the diffusion is reduced. The contrast between ischemic and 
nonischemic tissue increases (on the left side) with the diffusion weighting (b-value). (Adapted from 
Heiland 59) 
ADC value changes parallel with T2 in the ischemic development, from cellular energy 
failure, brain edema, till cellular necrosis. Based on experimental and clinical data, the MRI 
of ischemia evolving to infarction may be characterized by the following sequence of 
scenarios as illustrated in figure 9 and shown in table 4.  
 
Fig. 9. Diagram of the time course of ADC and T2 after artery occlusion. In hyperacute cerebral ischemia the 
ADC decreases. whereas there is no change in T2. A minimum ADC is reached at day 2 to 3, then ADC 
increases again. In the subacute stage of ischemia, ADC is still decreased, whereas there is a distinct T2 
increase. In chronic cerebral ischemia both ADC and T2 are increased. Adapted from S Heiland59. 
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Table 4. The characteristic appearance of acute ischemic infarction on ADC map, 
diffusion-weighted imaging and T2WI 
 Acute stage (minutes) Subacute stage (hours 
– days) 
9-10 days Complete infarction 
ADC Decrease, hypointense Decrease, hypointense Isointense 
(pseudonormalization) 
Increase, hyperintense
DWI  Hyperintense hyperintense hyperintense Hyperintense or 
isointense 
T2WI Isointense (not 
detectable) 
Hyperintense from 24 
hrs 
Hyperintense Hyperintense 
At these early time points, a low ADC and a hyperintensity on DWI would suggest membrane 
depolarization with water shift from extra- to intracellular space (cytotoxic edema). Without 
immediate reperfusion, regions with low ADC will most likely get infarcted. 
In the later stages (hours to days), low ADC values are still seen in regions exhibiting signal 
intensity increase in T2WI MRI. This can occur when cytotoxic cellular swelling (within 
intact cells) exists in regions of increased water content (vasogenic edema). 
In regions of complete infarction, both T2 and ADC are observed to be higher than normal 
within similar regional distributions. The corresponding histopathology of these regions 
indicates cellular necrosis, in which cell lysis breaks down water diffusion barriers leading to 
an increase in ADC. However, the “recovery” of ADC and hyperintensity on DWI to normal 
exhibits a high variety in the later steps, depending on type, size of infarction. 
DWI has been shown to be very accurate in the diagnosis of acute cerebral infarction, with 
reported sensitivities of 88% to 100% and specificities of 86% to 100% in clinical studies60-64. 
ADC changement does not uniquely occur in ischemia. There are number of pathologies that 
might cause ischemia-mimic, such as multisclerosis plaques, status epileptics, herpes 
encephalitis, abscess and etc53. Other MRI sequences including T1 and T2 change might help to 
distinguish ischemia from these entities. Consideration of vascular territories and clinical 
presentation will play an extremely important role in the differential diagnosis. 
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DWI mechanism is complex but its performance is quite convenient. In most hospitals it takes 
less than half minute scan time to get a series diffusion images and the ADC maps. 
2.3.2 Perfusion weighted imaging (PWI) 
There are two types of perfusion MRI, the first pass bolus tracking technique (also called 
dynamic susceptibility contrast-enhanced [DSC] imaging) and the arterial spin-labeling (ASL) 
method. Since the DSC method is more frequently used and is the clinical established method 
31, 65-69, it is also used in our study. This technique will be reviewed in the following. 
The DSC method was first proposed by Villringer and Rosen40, 70. For this method, a bolus of 
paramagnetic contrast agent is used to visualize the blood perfusing the capillary network in 
the brain; the signal change caused by the contrast agent molecules passing through the 
capillaries in a voxel is monitored by a repetitive MRI measures in the same region. (Figure 
10). 
The presence of contrast agent molecules causes changes in both T1 and T2* relaxation. T1 
effects, however, are small as the contrast agent does not cross the blood-brain barrier71. The 
T1 interaction is only strong for a very short distance and therefore it only affects protons 
within the capillaries, i.e. about 3–5% of the protons in brain tissue72. A stronger signal 
change is caused in T2*-weighted sequences by the unequal distribution of the contrast agent 
in the intravascular and the extracellular fluid space. This creates local field gradients, 
resulting in T2* shortening of the proton spin relaxation times. The radius of the T2* 
interaction is much larger than that of T1 as the surrounding tissue is also affected. The signal 
change is strong enough to monitor a contrast agent bolus passing through the brain. 
If a paramagnetic contrast agent is injected and the susceptibility effect of the bolus in the brain 
is followed with a rapid series of T2*-weighted images, a drop in signal that fades away after a 
few seconds can be measured. Normally, there is no difference between the two hemispheres 
(figure 10). Regions with little or no perfusion (e.g., ischemic tissue) allow passage of only a 
small amount of contrast agent and therefore remain bright. (figure 11). Thus, ischemic areas 
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can be detected on the original contrast-enhanced MRI series by means of the signal decrease. 
A low signal decrease indicates that the tissue is less well or not perfused. 
 
Fig. 10. Series of source images obtained at intervals during the perfusion imaging sequence. The initial 
gradient echo, EPI image (1) shows normal appearances before arrival of the bolus. The bolus arrives at 
image (2) and the concentration increases to a peak at image (3) where marked loss of signal is seen within 
the cortical vessels and brain parenchyma. The signal loss declines rapidly (4). The final image (5) shows 
appearances similar to those pre-contrast. The relatively low spatial and contrast resolution of the source 
images is apparent. 
 
Fig. 11. Source images of a dynamic susceptibility contrast enhanced MRI series in a patient with focal 
cerebral ischemia. Within the ischemic territory the signal decreases much less than in the normal tissue. 
The maximum signal decrease, however, does not correlate to any physiological parameter. For 
quantitative assessment of the hemodynamics, the signal time curve must first be transformed 
into a concentration-time curve. This can be done either in user-defined regions of interest (ROI) 
or on a pixel-by-pixel basis using the equation 2: 
                        
where C(t) is the concentration-time curve, S(t) is the signal-time curve, and S0 is the baseline 
signal determined by averaging the signal intensities before bolus arrival. 
The relative concentration of the contrast agent does not return to baseline after the bolus 
passage, but remains slightly increased; often a second passage of the bolus is visible (Figure 
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12). 
 
Fig. 12. Signal-time course in normally perfused tissue. The baseline is determined from the signal before 
bolus arrival. During first pass, there is a sharp signal decrease. The first pass is often followed by a second 
pass, with a signal decrease that is less steep than in the first pass. 59 
For calculation of the cerebrovascular parameter, only the first pass of contrast agent through 
the brain tissue can be considered. Therefore, recirculation effects have to be excluded. This 
can be accomplished either by interactive truncation of the second pass or by fitting a gamma 
variate function to the measured concentration-time curve (Figure 13):                      
 
Fig. 13 Concentration-time course in normally perfused tissue. A gamma variate function is fitted to the 
curve to avoid effects of persistent contrast agent and of the second pass. 59 
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The parameters A, B, D, and bolus arrival time (T0) are then determined by an iterative fitting 
algorithm using the least-squares method73. According to the indicator-dilution theory74 the 
relative regional blood volume (rrCBV) can be calculated as the area under the 
concentration-time curve, the relative mean transit time (rMTT) is approximately the width at 
half maximum of the concentration-time curve, and the time to arrival (TTA) as the time 
between bolus injection and appearance of the first contrast agent molecules in the capillaries 
(Figure. 14)73, 75, 76. TTA corresponds to the parameter T0 of the gamma variate function 
already mentioned. Some manufacturers calculate the TTP instead of rMTT. TTP and rMTT 
are inversely correlated with the CBF, i.e., low regional CBF results in high TTP and rMTT77.  
 
 
Fig. 14. Various cerebrovascular parameters can be calculated from the concentration-time curve: (a) 
rrCBV is defined as area under the concentration-time curve, (b) rMTT is the width at half maximum of the 
curve, (c) TTA is the time between contrast agent injection and arrival of the first contrast agent molecules 
within the region of interest, and (d) TTP is the time between contrast agent injection and the maximum 
contrast agent concentration within the region of interest. 59 
Although these are relative parameters, they are sufficient for examining a focal disease. 
Hemodynamic parameters calculated in diseased area can be compared with the parameters of 
normal tissue59. In diseases affecting hemodynamics of the whole brain, however, the 
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quantitative parameters must be calculated. This can be achieved by measuring the AIF and 
deconvolution of the tissue concentration-time curve78-80.  
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2.4 MRI protocol 
All MR imaging was performed on a 1.5-T whole body system (Magnetom Vision; Siemens, 
Erlangen, Germany), using the standard head coil for radiofrequency (RF) transmission and 
detection. After a localizer, T2- and T1-weighted spin-echo sequences with 19 sections were 
acquired, covering the whole brain (T2: 2210/85 ms, 14/1 [TR/TE/number of excitations]; T1: 
665/14/1 ms, 5-mm section thickness, 210-mm field of view). The gap between slices in both 
T1- and T2-weighted sequences was 1.5 mm. DWI and PWI were also performed with the 
following protocol. 
DWI 
DWI was performed using a multislice, single-shot, spin-echo EPI sequence. The diffusion 
gradient was applied in three dimensions, with three b values ranging from 50, 500 to 1,000 
sec/mm2. Typical imaging parameters were an echo time (TE) of 137 msec, matrix size of 128 
x 128, field of view (FOV) of 250 mm, slice thickness of 5 mm (gap between slices 1.5 mm), 
and a set of 19 axial slices. To minimize the effects of diffusion anisotropy, an average of all 
three diffusion directions was calculated to give the trace of the diffusion tensor. Only the 
DWI map when b=1000 sec/mm2 were chosen as the map to measure the abnormalities 
volume, and the hyperintensive abnormality was recognized as the ischemic core. (Figure 15). 
PWI 
PWI was performed before, during, and after bolus injection of a standard dosage71 of 0.2 
mmol/kg contrast material (Ominiscan, Nycomed Imaging AS, Oslo, Norway; Magnevist, 
Schering, Berlin, Germany) injected by a power injector (Spectris; Medrad, Volkach, 
Germany) at a rate of 5 cc/s. Echo-planar sequence was performed with the following 
parameters: echo time (TE) 60.7 msec, repetition time (TR) 2 seconds, FOV 240 mm, 
acquisition matrix 128 x 128, and the slice thickness was 5 mm with the gap between slices of 
1.5 mm. The perfusion sequence had 12 slices, which were positioned to cover the region 
suspected to be ischemic based on the extent of abnormal signal intensity on the DWI. (Figure 
15).
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Fig. 15. The upper row is the DW images. The lower row is the TTP images of PWI. 
On DWI, the ADC map the ischemia is hypointensive, while the ischemia contrast to nonischemic tissue 
increased when b value increased. On PWI, TE=60.7 msec, TR=2 seconds, FOV 240 mm, matrix 128 x 
128. Notice the diffusion/perfusion mismatch. Only the hyperintensive abnormality on DWI when 
b=1000sec/mm2 were used to compare the hyperintensive abnormality on corresponding PWI TTP images. 
The raw images of DWI and MR angiography were interpreted in consensus by two 
experienced radiologists (RB, JM) without the knowledge of the clinical information of the 
patients.  
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2.5 Data processing 
The raw perfusion scanning data were transferred to a Linux Red Hat workstation for further 
processing. All the post-processing was done with MEDx 3.4.1® (Sensor Systems, Virginia, 
US). Image processing of all dynamic data was performed on a pixel-by-pixel basis 
calculating a gamma fit. AIF was determined using both time curves and anatomic overlay. 
The first pass arterial response was based on fitting a gamma-variate function to the arterial 
data. Analysis of the PWI included calculation of territorial CBV, CBF, MTT, T0 and TTP. 
The following analysis or measurement was performed without knowledge of the patients’ 
symptoms. 
On the perfusion MRI map, ROIs were manually drawn contoured in ischemic core 
(hyperintensive area on DWI map when b=1000 s/mm2) and the diffusion/perfusion mismatch 
area (the area normal on DWI, but abnormal on TTP), and in both normal mirror area. The 
apparent TTP maps were chosen to delineate perfusion abnormalities. To minimize errors 
related to imprecise coregistration and contouring, the perfusion parameters were calculated 
only in ROIs that were larger than 30 mm2 in ischemic core and in ROIs that were larger than 
60 mm2 in diffusion/perfusion mismatch areas. Finally there were two sets of ROIs were 
established and were copied and pasted to all the maps as CBV, CBF, MTT, TTP and T0 for 
each case. (Figure 16). With MEDx, the original values of the hemodynamic parameters were 
automatically calculated and displayed.  
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Fig. 16. On a. DWI the 
hyperintensity was 
recognized as ischemic 
core; and on b. TTP, the 
area normal on DWI but 
abnormal on MTT map was 
recognized as mismatch;  
On c. CBV; d. CBF; e. 
MTT; f. TTP and g. T0 
maps, the ROIs were 
manually drawn in the 
ischemic core and the 
mismatch region on the 
perfusion maps, and were 
rotated to the mirror region 
on each map. 
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Calculation of perfusion parameters. The original value of the CBV, CBF, MTT, T0 and TTP 
of each territory was obtained in ischemic core, mismatch region and the contralateral mirror 
regions. The relative perfusion values (rCBV and rCBF) were then calculated as ratio of value 
in diseased area and the contralateral mirror area (equation 3), while the time parameters 
(MTT, T0 and TTP) were the difference between the diseased area and the mirror area:        
relative value of parameter=(Pdisease-Pmirror)/ Pmirror x100%                    3 
where Pdisease means the parameters in disease area, and Pmirror means the parameters in normal 
mirror area. 
Measurement and calculation of the volume in both DWI and PWI. On MEDx, drawing of the 
ROIs manually along the contour of the hyperintensive abnormalities on DWI and PWI 
images (figure 17) on each slice was used to derive the quantitative area values. With the area 
values timed the slice thickness and gap, and then added, the volume (in cm3) value was 
achieved. The diffusion/perfusion volume ratio was calculated according to the following 
formula 4: 
Ratio= Volume on DWI/ Volume on PWI                   4 
 
Fig. 17. DWI and PWI images. The ROIs were drawn contouring the hyperintensive abnormalities on the 
images. The volume equals to area x (slice thickness+gap). The diffusion/perfusion volume ratio is <1/3 in 
this patient. 
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2.6 Statistics 
Statistical analysis was performed using the SPSS software package, version 11.0 (SPSS, Inc, 
Chicago, USA). One way analysis of variance was used to determine whether significant 
differences existed between the time to scan, age, sex, NIHSS and MRS between groups of 
good outcome and poor outcome. This one way analysis of variance was also used in analysis 
of age, sex, NIHSS and MRS between groups of volume ratio greater than 1/3 and less than 
1/3. Linear regression was used to evaluate the relation between rCBV, rCBF, MTT, TTP and 
T0 values, and NIHSS and MRS in both the infarcted core and mismatch regions. Mean value 
plus standard deviation (SD) was used to give the average value of rCBV, rCBF, MTT, TTP 
and T0 in both infarcted core and mismatch region. Paired-samples T test was used for 
evaluation of the relation between NIHSS and MRS.  
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3 RESULTS 
3.1 General  
In the patients group (n=35), time between ictus to MRI scan ranged from 0.9 to 72 hours. 
There were 21 patients examined by MRI within 6 hours, and 14 patients between 6 and 72 
hours. The average volume of the hyperintensive abnormalities on DWI was 22.5 (range: 5.2 
to 122.4) cm3, and the average volume of hyperintensive abnormalities on PWI was 124.3 
(range: 23.4 to 465.8) cm3. The volume ratio of diffusion/perfusion was less than 1/3 in 30 
patients (85.7), and ratio greater than 1/3 in 5 patients (14.3%).  
MRA was available in 25 patients (71.4%). Patency of the artery on the basis of MRA at the 
time of MRI scan was shown as follows: 0% patency (occluded, n=16), 10-60% patency 
(partially open, n=6), and 100% patency (totally open, n=3). 
In this patients group, 6 (17%) patients received intravenous thrombolysis (within 3 hours at 
the standard dose), 9 (25%) patients received intraarterial treatment as exclusion criteria for 
the intravenous thrombolysis existed, 3 (9%) patients received both intravenous and 
intraarterial treatment. All of the above patients were managed in combination to intensive 
care treatment. 17 (49%) patients received intensive care treatment only including secondary 
stroke prophylaxis treatment. 
The NIHSS score of the patients at initial examination ranged from 0 to 19 (10.2±4.4). The 
outcome MRS scale ranged from 0 to 6 (mean: 3.23). A good outcome (MRS 0 to 3) was 
observed in 19 patients (54.3%), whereas 16 patients (45.7%) had a poor outcome (MRS 4 to 
6). In the latter group, MRS showed that 10 patients had scale 4, 2 patients had scale 5 and 4 
patients had scale 6 (death).  
Between the good and poor outcome groups, time to scan (17.1±22.1 versus 11.1±12 hours), 
DW/PW volume ratio (0.40±0.15 versus 0.36±0.11), age (59.6±16.7 versus 63.2±13.5 years) 
and female/male ratio (9/10 versus 6/10) did not show significant differences. (Table 5) 
The mean NIHSS score was 9±5.3 in the group with good outcome, and 11.6±3.5 in the group 
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with poor outcome; Although there was a trend that lower NIHSS score had good outcome 
and high NIHSS had poor outcome, it did not reach statistical significance in our group. 
Table 5. Relationship Between Stroke Outcome, time to scan, NIHSS, volume ratio, age and sex ratio. 
Outcome 
 
Good* (n=19) Poor* (n=16) 
p 
Time to scan (h) 17.1±22.1 11.1±12 .346 
NIHSS 9±5.3 11.6±3.5 .089 
Volume ratio (DW/PW) 0.4±0.2 0.4±0.1 .322 
Age (y) 59.6±16.7 63.2±13.5 .498 
Female/male ratio 9/10 6/10 .570 
*Good outcome indicated the MRS ranged from 0 to 3, and a poor outcome indicated that MRS ranged 
from 4 to 6. 
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3.2 MRI hemodynamic parameters evaluation 
Ischemic core 
rCBF showed a remarkable decrease in all patients on average by 59.3±33.7% (range: 23.2 - 
97.4%). rCBV decreased in 29 patients by 41.7±23.7% (range 19.6 - 55.6%), while 6 
patients showed an increase of rCBV by 60.4±57.1% (range 0.7 -139%). The mean rCBV 
change of the entire group was 26.3±52.5%. MTT, TTP and T0 prolonged for 4.7 (SD=15.1), 
2.8 (SD=12.9) and 0.5 (SD=10.4) seconds, respectively. 
Mismatch region 
The evaluation of rCBF showed two controversial trends in the patients group, as rCBF 
decreased in 15 patients by 26.2±19.9% (range: 5.3-58.4%) while increased in 20 patients by 
35±23.2% (range: 6.8–74.4%). As a result, the change of the rCBF of the whole patients 
group was on average 5.8±38.4%. rCBV decreased in 7 patients by 14.7±16.5% (range: 
0.8-44.5%) and increased in 28 patients by 39.5±36% (range: 2.2-91.1%). The mean change 
of the rCBV of the whole group was 19.9±31.2%. The mean value of MTT, TTP and T0 
prolonged for 2.7 (SD=8.5), 3.2 (SD=5.2) and 1.3 (SD=4.2) seconds respectively. 
Figure 18 to 21 show four examples of MCA territory ischemia. 
  
41
 
        
           
 
Fig. 18. K. R. Male, 61. Left hemiparesis. Ischemia on right MCA territory. NIHSS score was 12. The 
immediate study (4 hours after onset) showed an ischemia with a large DWI-PWI mismatch in the right 
MCA territory. Volume ratio was greater than 1/3. The ROIs for the hemodynamic parameters were drawn 
on ischemic core and the mismatch region, and on the normal mirror region. Patient received systemic 
thrombolysis and mechanical recanalization. Patient deceased in the course of the disease (MRS=6). a. 
DWI showed relative small hyperintensive abnormality, while b. PWI showed larger hypertensive 
abnormality. c. CBV map, rCBV decreased by 89.4% in core and 44.5% in mismatch. d.CBF map. rCBF 
decreased by 97.4% in core and 63.3% in mismatch region; e. MTT map. MTT prolonged 24.1s in core and 
12.3s in mismatch region; f. TTP map. and g. T0 map. TTP shortened 32.2 s and 7.6 s in core and 
mismatch region, T0 shortened 22.6 s and 6.4 s in core and mismatch region correspondingly. 
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Fig. 19. Patient K.W., M, 72. Aphasia and weakness of right arm. NIHSS 
score 7. Time to MRI was 15 hours. T1 (a.) and T2 (b) weighted images 
were negative. In the DWI (c) small fresh territorial ischemia was found at 
the island and subcentral area on the left. In PWI (d), a clear larger area of 
deficit was shown on the left. Volume of DWI/ Volume of PWI ratio was 
<1/3. On the time of MRI scan, 100% patency of the right MCA. 
Although in the core, both rCBV and rCBF decreased by 25.4% and 
28.4%, in mismatch region the rCBV and rCBF increased by 39.3% and 
45.7% comparing to the mirror region. A reserved perfusion or 
reperfusion might exist. Only secondary prophylaxis was carried out. The 
patient had a full recovery from his stroke symptom (MRS=0). 
e. rCBV; f. rCBF; g. MTT; h. TTP; and i.T0 maps. j. MRA. 
 
rCBF 
increased in
mismatch 
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Fig. 20 L. F. M/67. The patient could not speak and his right side could not move. The initial NIHSS was 
12. CT (a)found a dubious hypodense on the lens. Both DWI and PWI (c and d) showed a hyperintensive 
deficit on left MCA territory. DSA (b) showed occlusion was in the proximal M1 segment. A spontaneous 
reperfusion was established at the time of MRI within 2.5 hours after onset.  
After the systemic thrombolysis, a mechanical inspiration by means of Angiojet was successfully 
performed. His MRS outcome score was 4. 
 
The arrow points the core region on DWI.  
The red arrow      points the mismatch on TTP map.  
Notice the green up region pointed by arrow      ,  where the rCBF is 1.91, almost twice of that of the 
mirror region. This might be interpreted as spontaneous reperfusion. 
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Fig. 21. Patient M/62, aphasia and hemiparesis left. NIHSS score 14. Time to MRI scan 48 hours. a and b: 
DWI and PWI, both DWI and PWI showed an ischemic deficit on the right. A mismatch exists, with 1/2< 
volume of DWI/volume of PWI <1. c. MRA showed a right carotid artery and MCA occlusion. d- h. rCBV, 
rCBF, MTT, TTP and T0 maps. In the ischemic core, rCBV and rCBF decreased by 55.6% and 67.1%, 
while in mismatch region rCBV and rCBF increased by 27.4% and 74.4% in comparison to the mirror 
region correspondingly. i. Follow-up (58days) CT confirmed that the size of the infarction was smaller than 
that on both DWI and PWI. The patient presented a clear recovery from hemiparesis and could move within 
the rolling-chair. MRS 4. 
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3.3 Hemodynamic parameters in relation with assessment of stroke severity (NIHSS) and 
outcome (MRS) 
3.3.1 Hemodynamic parameters in relation to NIHSS 
Ischemic core 
There was no statistic significance (p>0.05) between each hemodynamic parameters derived 
from ischemic core (figure 22-26) with the stroke severity (NIHSS) score.  
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Fig. 22. Graphic demonstration of the 
relation of rCBV with NIHSS in ischemic 
core region. (p=.894) 
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Fig. 23. Graphic demonstration of the 
relation of rCBF with NIHSS in ischemic 
core region. Notice there was a trend that 
the more the rCBF decrease the higher the 
NIHSS (the severe the symptom was) 
although there was no statistic significance 
shown (p=.122) 
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Fig. 24. Graphic demonstration of the 
relation of MTT with NIHSS in ischemic 
core region. (p=.134). 
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Fig. 25. Graphic demonstration of the 
relation of TTP with NIHSS in ischemic 
core region. (p=.147). 
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Fig. 26. Graphic demonstration of the 
relation of T0 with NIHSS in ischemic core 
region. (p=.549). 
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Mismatch region 
There was no statistic significance (p>0.05) between each hemodynamic parameters derived 
from mismatch region (figure 27-31) with the stroke severity (NIHSS) score, with the 
exception of TTP which showed a strong statistic correlation with NIHSS (p=0.001). 
Prolongation or delay of TTP therefore was related to more severe stroke symptoms.  
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Fig. 27. Graphic demonstration of the 
relation of TTP with NIHSS in mismatch 
region, (p=.001), without including 
constant in equation. Delay of TTP in 
mismatch region was related to NIHSS: the 
longer the delay, the severe the symptoms 
were.  
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Fig. 28. Graphic demonstration of the 
relation of rCBV with NIHSS in mismatch 
region, (p=.715). 
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Fig. 29. Graphic demonstration of the 
relation of rCBF with NIHSS in mismatch 
region, (p=.556). 
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Fig. 30. Graphic demonstration of the relation 
of MTT with NIHSS in mismatch region, 
(p=.660). 
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Fig. 31. Graphic demonstration of the 
relation of T0 with NIHSS in mismatch 
region, (p=.064). 
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3.3.2 Hemodynamic parameters in relation to MRS 
Ischemic core 
rCBF regressed statistically significant with MRS (P=.0003). It showed the trend that higher 
rCBF in the core related to less MRS (better outcome), and vice versa. (Figure 32). MTT also 
showed statistic significance of regression with MRS. Prolongation or delay of MTT related 
to higher MRS (worse outcome). (Figure 33). No statistic significance between other 
parameters with the MRS outcome scale. (Figure 34-36) 
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Fig. 32. The relation of rCBF with the MRS 
outcome scale on ischemia core region. 
Notice the tendency that decreased rCBF 
correlated with high MRS (worse outcome), 
and increased rCBF had lower MRS (better 
outcome) (p=.0003). 
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Fig. 33. On ischemic core region, the graphic 
relation between MTT and MRS outcome 
scale, (p=.033). Notice that the delay of 
MTT was related to higher MRS (worse 
outcome). 
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Fig. 34. On ischemic core region, the graphic 
relation between rCBV and MRS outcome 
scale, (p=.415). 
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Fig. 35. On ischemic core region, the graphic 
relation between TTP and MRS outcome 
scale, (p=.301). 
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Fig. 36. On ischemic core region, the graphic 
relation between T0 and MRS outcome 
scale, (p=.769). 
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Mismatch region  
rCBF was elevated in 22 patients (72%), possibly representing preserved perfusion or 
reperfusion establishment at the time of MRI. The rCBF value correlated significantly to 
MRS (P=0.004) (figure 37). There was a tendency that the higher the rCBF, the better the 
outcome. TTP was also regressed significantly with the MRS outcome scale (p=0.006). It 
showed the trend that delay of TTP might have higher MRS scale or worse outcome (figure 
38). The rest of the parameters did not regress significantly with the MRS outcome scale 
(figure 39-41). 
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Fig. 37. The relation of rCBF with the MRS 
outcome scale on mismatch region. 
(p=.004). The lower rCBF correlated with 
worse outcome (high MRS) and the higher 
rCBF with better outcome (low MRS). 
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Fig. 38. The relation of TTP with the MRS 
outcome scale on mismatch region. 
(p=.006). The delay of TTP might have 
higher MRS scale or worse outcome.  
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Fig. 39. In mismatch region, the graphic 
relation between rCBV and MRS, (p=.539).  
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Fig. 40. In mismatch region, the graphic 
relation between MTT and MRS, (p=.060). 
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Fig. 41. In mismatch region, the graphic 
relation between T0 and MRS, (p=.131). 
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Table 6 provides the summery of statistic p value between hemodynamic parameters and 
NIHSS and MRS in both core and mismatch region. 
Table 6. Summery of the statistic p value between hemodynamic parameters and NIHSS and 
MRS in both core and mismatch region 
 
 core mismatch 
 p (NIHSS) p (MRS) p (NIHSS) p (MRS) 
rCBV .894 .415 .715 .539 
rCBF .122 .0003* .556 .004* 
MTT .134 .033* .154 .060 
TTP .147 .301 .001* .006* 
T0 .549 .769 .064 .131 
*statistically significant 
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3.3.3 NIHSS and MRS in relation to other factors 
Statistic significance was found between NIHSS and MRS (p=0.008). (figure 42).  
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Fig. 42. Graphic demonstration of the 
relation between NIHSS and MRS. Statistic 
significance was found (p=.008). 
No statistic significance was found between age and sex with NIHSS (figure 43-44), and 
between age and sex with MRS (figure 45-46).  
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Fig. 43. Graphic relation between age 
and NIHSS, (p=.112). 
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Fig. 44.  Graphic relation of sex with 
NIHSS (p=.568) 
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Fig. 45. Graphic relation between age 
and MRS, (p=.455) 
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Fig. 46. Graphic relation of sex with 
MRS (p=.636). 
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No statistic significance was found between patency of the occluded artery at the time of 
MRA with NIHSS (figure 47), and with MRS (figure 48). 
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Fig. 47. Graphic relation between the 
percentage of patency of the occluded 
artery and NIHSS, (p=.334). 
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Fig. 48. Graphic relation between the 
percentage of patency of the occluded 
artery and MRS, (p=.266) 
 
Between groups of volume ratio less than 1/3 and volume ratio greater than 1/3, there was no 
statistic difference in: age (61.83±13.57 vs 57.8±24.68 years) (p=.590); NIHSS score 
(10.1±4.28 vs 10.6±5.9) (p=.820) and MRS outcome scale (3.47±1.57 vs 2.6±0.89) (p=.241). 
.  
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4 DISCUSSION 
4.1 Finding and impact of the present study 
The outcome of ischemic stroke is influenced by a variety of factors including site and size of 
the ischemia, and other combined factors81, 82. Our intention was to evaluate the hemodynamic 
parameters in mismatch regions as well as in ischemia core, to find out if the parameters could 
be useful to predict clinical severity and outcome of acute stroke. 
In the present study, data showed that rCBF value were useful in prediction of the stroke 
outcome. rCBF decreased in the ischemic core region in all the patients, while in the 
mismatch region the rCBF measurement was shown to be either decreased or increased. The 
decrease of rCBF in both core and mismatch region was interpreted to be due to the occlusion 
of the supplying artery and the reduction of perfusion before autoregulation mechanisms were 
able to compensate. The more the rCBF was decreased in both regions, the worse the outcome 
was (figure 32, 37). The interesting findings in mismatch region were that the more increase 
of the rCBF the better outcome would be, and vice versa. The findings of increased rCBF in 
the mismatch region (in 28/35 patients) might be due to either a preserved perfusion or 
establishment of reperfusion occurred in the tissue at risk--penumbra. Heiss et al.28 used 
[15O]-H2O PET to investigate the penumbra before and after thrombolysis in a group (12 
patients), and found out that the penumbra could be preserved by reperfusion. Baird et al.83 
studied a group (22 patients) with 99mTc-hexamethylpropyleneamine oxime single photon 
emission computed tomography (SPECT), and found that those with no reperfusion after 
streptokinase administration had higher mortality rate, less neurological improvement and 
more disability than those who had reperfusion. In his later SPECT studies, Baird et al84 
concluded that changes in cerebral tissue perfusion during the first 48 hours of ischemic 
stroke are significant outcome predictors. Our study added to previous researches by 
emphasizing the importance of quantifying the rCBF in both core and mismatch region, and 
especially by identifying the probable “reperfusion” in mismatch region to predict the 
outcome in acute stage with the tool of MR imaging.  
In the acute period of a ischemic stroke, the rate of spontaneous reperfusion relevant for 
  
58
 
induced thrombolysis appears to be less than 20%85. Thrombolysis is more effective to 
occlusions caused by an embolus rather than a thrombus, although there is an exception that if 
the embolus is well organized as seen in rheumatic heart disease86. It has been shown that 
spontaneous reperfusion is associated with better clinical outcome and smaller size of the 
infarction81, 87. For a positive treatment decision, the reopening of the vessel (e.g.: MCA) can 
be detected by MRA. However, it is difficult or impossible to distinguish between a 
spontaneous reperfusion or embolus migration with MRA. Partial reperfusion or embolus 
migration is known to occur in human stroke. If a proximal thrombus causing a MCA 
occlusion migrates distally in the supply territory, a cortical area rescued from infarction by 
meningeal collateral blood supply collaterals can become infarcted when the migrated 
occlusion is situated distal to the collateral anastomoses. It is also known that reperfusion into 
the ischemically injured vessels can therefore result in blood extravasation through the 
damaged blood-brain barrier and cause hemorrhagic infarction. To measure the cerebral 
reperfusion, PET and SPECT has been well accepted as established tools84, 88. Using perfusion 
MRI, Marks et al89 interpreted the reperfusion as normalization on PWI on MRI in a 12 
patients group, while Barber et al90 recognized reperfusion by calculating the volume ratio 
according to the formula [(acute PWI-subacute PWI lesion volume)/ acute PWI lesion volume] 
with the idea that the PWI volume may be contracted in subacute stage than in acute stage if 
reperfusion established. Our study interpreted the increase of rCBF in mismatch region 
compared with the mirror region as reperfusion and found out that those with this reperfusion 
showed better outcome. 
TTP was shown to be useful for prediction of both NIHSS and MRS in mismatch region in 
the study. The average delay of TTP was 3.2 seconds in the mismatch region on average 
despite a relative high standard deviation. This delay of TTP was related to severe clinical 
symptom and worse outcome. Neumann-Haefelin et al91 found that TTP delay correlated with 
European Stroke Scale (ESS). Though we used different stroke scales, the result of our study 
of TTP had correlation to stroke severity and was in limits matched to their study. Grandin et 
al92 studied the relation of perfusion parameters and infarct growth and found that the TTP 
combined with peak height had the best sensitivity (71%) and specificity (98%) to predict the 
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final infarct volume, which in turn was the strongest prognostic factor on stroke outcome93-95. 
We found delay of MTT, in the ischemic core, was correlated significantly with the outcome 
measured with MRS. The more the MTT delay, the poorer the outcome was. However, 
changes of MTT in the mismatch region did not show significant correlation to NIHSS or 
MRS, as might have been expected. The rCBV showed no statistic significance to NIHSS or 
MRS in both core and mismatch region. We assume that rCBV might be influenced by 
compensatory mechanisms like vasoreactivity more than the other parameters discussed 
above. This in turn may have had an effect on parts of the patients group, resulting in an 
inhomogeneous correlation (figure 28 and 34). It is believed that in cerebral ischemia, MTT 
increases immediately after vessel occlusion96, 97; parallel to the change in MTT there is a 
rCBV decrease, particularly in the infarction core. In small lesions, however, rCBV is not 
reliable98. Furthermore, there may be an increase in rCBV in the border zone of the 
hypoperfused tissue related to compensatory vasodilatation99. Because of this inhomogeneous 
behavior of rCBV, MTT and rCBF are considered the most important and reliable 
cerebrovascular parameters in acute ischemia100. 
The use of perfusion parameters to predict the outcome of ischemic stroke has been evaluated 
earlier. Barber et al87 used 99Tc-hexamethylpropyleneamine oxime (99Tc-HMPAO) SPECT to 
examine 41 acute ischemic stroke patients, and found spontaneous reperfusion is associated 
with improved outcome. However, neither proportions of the perfusion nor complications 
such as bleeding can be determined in a single SPECT study, which makes the emergent 
management of acute stroke unpractical. Fiehler et al101, in a acute stroke patients group of 32 
patients, used MRI derived CBF to predict the infarction growth and released a light for 
further prognostic estimation using perfusion parameters. Seidel et al102 used ultrasound 
perfusion imaging in a 23 patients group study, and showed bolus harmonic imaging a useful 
tool for analyzing cerebral perfusion deficits, and found bolus harmonic imaging data 
correlated with the outcome of stroke after 4 months.  
The study of Warach et al103 was the first which compared neurologic outcome with the 
presence or absence of DWI abnormalities in 12 patients with acute ischemia of less than 6 
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hours duration. DWI and PWI were found to be highly sensitive and specific in predicting 
persistent neurologic deficits and accurate determined outcome in 11 (91%) of 12 patients. 
However, no accepted stroke scales were used to quantify the severity of neurologic deficit, 
and stroke volumes could not be assessed because only single slice DWI and PWI images 
were obtained in most patients.  
Other studies regarding MRI diffusion/perfusion mismatch volume with the prediction of 
severity of ischemic stroke were reported. Beaulieu et al 94 studied a ischemic stroke group 
(21 patients) and found the diffusion/perfusion mismatch volume correlated well with initial 
NIHSS and outcome. Uno et al104 used the mismatch ratio percentage ([initial PWI-initial 
DWI/initial PWI] x 100) and the rescued ratio percentage ([initial PWI-final T2/initial PWI] x 
100) for evaluation of 10 patients who received thrombolysis recanalization. He found the 
mismatch ratio was significantly correlated with initial NIHSS score, and the rescued ratio 
may be an objective indicator of the efficacy of treatment. However, these studies 
concentrated more on the mismatch volume rather than the perfusion parameters. 
To use perfusion parameters to predict the outcome, there is a difficulty to overcome: 
calculation of the quantitative (or absolute) perfusion parameters. Technically, calculation of 
quantitative perfusion parameters requires dedicated software and some awareness of the user. 
On the other hand, in most clinical studies, perfusion analysis needs prompt assessment and 
thus only relative measurements (ratios or differences between the abnormal area and a 
contralateral normal area) are available. The easiest method is to calculate relative parameters 
on the tissue curve without any deconvolution, but this does not provide absolute or 
quantitative measurement of CBF and other hemodynamic parameters. However, a recent 
study compared relative values of six parameters (MTT, TTP, T0, CBV, Peak height, CBF 
index or CVF) with the corresponding quantitative value, and showed the same accuracy of 
both relative and absolute values to predict infarction growth92. Their result potentially 
indicated that relative value of the hemodynamic parameters may be used as absolute value 
equally in evaluation of ischemic stroke. According to this, we calculated the relative 
parameters as ratio (rCBV, rCBF) and difference (MTT, TTP and T0) between the abnormal 
and contralateral mirror region instead of absolute values in our study. 
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The advantage of relative parameter assessment is that the values are quickly and easily 
obtained, which is especially crucial for clinical setting when to manage a hyperacute stroke 
patient. The disadvantage of relative values is the difficulty to use them prospectively. They 
necessitate the definition of an ROI and its normal mirror ROI, but the contralateral 
hemisphere is not always normal, and that may bias the results. A solution for routine practice 
is to use small ROIs on both diseased and mirror region, but this reduces considerably the 
spatial resolution of the method, probably does not resolve the problem of the normality of the 
mirror ROI, and costs additional time92. 
4.2 Penumbra and Mismatch 
As many of the authors105-107 emphasized, the target of current neuroprotective therapy is to 
save the tissue at the penumbra, the ischemic tissue that is functionally impaired but whose 
damage is potentially reversible108, 109. If reversible ischemic tissue is not present at the time 
of treatment, then neuroprotective therapy cannot be expected to be sufficient105, 110. 
The ischemic penumbra was defined by Astrup et al21 as brain tissue perfused at a level within 
the thresholds of functional impairment and morphologic integrity, which has the capacity to 
recover if perfusion is improved. Because tolerance of tissue to ischemic damage is dependent 
on residual flow and duration of flow disturbance111, the ischemic penumbra is a dynamic 
process; it exists for a short period even in the center of ischemia, from which the conversion 
into irreversible necrosis propagates over time to the neighboring tissue. This also makes the 
time window of the various therapeutic approaches variable and ill-defined; the time interval 
given usually is too short for the core of ischemia and may extend to several hours in the 
moderately ischemic surrounding tissue. The concept of the ischemic penumbra has been 
developed from animal experiments. Its transfer to the clinical situation requires the definition 
of three critical values that can usually not be assessed easily in the acute stages of ischemic 
stroke: (1) the flow threshold for functional impairment—to identify functionally impaired 
tissue; (2) the flow threshold for morphologic damage—to identify irreversibly damaged tissue; 
(3) the time period a tissue tolerates flow decreased to a certain value before it becomes 
irreversibly damaged—to predict recovery of function with reperfusion. 
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In the early 1980s, PET imaging was used to define the penumbra as a mismatch between CBF 
and oxygen (O2) metabolism, with oxygen metabolism relatively maintained, despite severe 
hypoperfusion. The penumbral signature using PET was defined by an increased oxygen 
extraction fraction, termed ‘misery perfusion’ by Baron et al.112. Though some validated 
absolute thresholds for the CBF boundaries of the penumbra were reached, the notion of a 
specific CBF threshold is relatively meaningless if it is not integrated with temporal, 
therapeutic and tissue factors. With the limited availability of PET machines, radiation 
exposure and the necessity of catheterization constrain the use of PET as a tool for managing 
acute stroke patients and assessing investigational therapies44. PET imaging, in an acute setting, 
was not available at our university hospital due to the reason of tracer availability at emergency 
condition. In contrary, the combination of PWI, DWI and MRA provides a feasible setting for 
acute stroke evaluation and is routinely performed in our and many other centers. Using the 
concept of mismatch with PWI>DWI, the high-intensity signal observed on DWI indicates the 
tissue usually destined to infarct, while the typically larger, hypoperfused region with 
prolonged mean transit times is regarded as the tissue at risk. The mismatch between the two 
images is postulated to represent the penumbra.  
Recently, there have been two modifications made to the MRI-based penumbral concept. The 
first of these stemmed from the recognition that within the region of hypoperfused tissue, as 
measured using mean transit times (MTT), there are varying degrees of hypoperfusion. For 
example, Parsons et al66 showed that regions of very severe hypoperfusion, with MTT 6 s 
compared with the normal hemisphere, nearly always went on to infarct, whereas those with 
lesser degrees of hypoperfusion (MTT delay of 4-6 s) had a variable likelihood of progression 
to infarction. Regions with MTT delays of 2-3 s typically survived, and have been assigned as 
regions of benign oligaemia. More recently, Butcher et al.100 showed that perfusion thresholds 
for infarction were time-dependent in the first 6 hours after stroke and that more severely 
hypoperfused tissue, usually destined to infarct, could be rescued by thrombolysis. The 
second modification to the original penumbral concept was the recognition that the 
hyperintense DWI lesion does not always go on to frank infarction.  
The concept of diffusion/perfusion mismatch is facing challenge. Fiehler et al 113, 114 studied 
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the ADC maps with the infarction volume in acute stroke patients, and found that the 
decreased ADC at early time might normalize in stroke patients (4/15) due to reperfusion. 
Kidwell et al115 showed that a portion of the DWI core could be salvaged by intra-arterial 
thrombolysis. These regions are likely to correlate with less severely attenuated ADC values. 
This finding in human stroke replicated animal DWI studies indicating reversibility116. The 
original ischemic core volume based on DWI might not keep a constant size at different time 
points in acute stroke, therefore, the diffusion/perfusion mismatch might therefore 
overestimate the penumbra32, 117. 
Therefore, it is seems necessary to use the concept of diffusion/perfusion mismatch with care 
in clinical practice. However, the importance of the predictive value as rCBF, TTP in 
mismatch region and rCBF and MTT in the core region could not be neglected. As a quick 
and feasible visual recognition of penumbra, mismatch and the hemodynamic parameters 
derived is informative to clinician and beneficial to stroke patients.  
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4.3 Other methods of neuroimaging to assess acute stroke 
During the past thirty years, advances in neuroimaging technology have resulted in an imaging 
revolution that led to a much better understanding of cerebrovascular and tissue pathology. 
Advances include early and accurate detection of ischemic and infarcted tissue and also the 
ability to reveal hypoperfused tissue at risk. Clinicians are increasingly relying on noninvasive 
methods to detect embolic and atherothrombotic intravascular lesions. CT, MRI, PET 
ultrasound and catheter angiography, each of which plays a specific role in clinical practice and 
research. Since MRI was introduced previously, it will not be reviewed here.  
 
Computed Tomography 
CT images of the brain are produced by scanning a collimated beam of x-rays through the brain 
in thin and sequential slices. CT scanning, with its advantages of quick scanning, adaptable for 
emergent patients who have a pacemaker or are on a ventilator, is widely available. In addition, 
interpretation in the hyperacute stroke setting is fairly straightforward without the need for 
special training. 
CT delivers two important informations to evaluation of stroke: (1) Is there intracranial 
hemorrhage and (2) Are there early infarct signs and what is their extent? For ischemic stroke 
within the first hours, CT is usually not sensitive in the identification of cerebral infarction at 
hyperacute stage. There are, however, some early signs of infarction such as sulcal effacement 
with loss of gray-white differentiation in superficial cortical infarction, hypodensity of the 
basal ganglia in cases of deep cerebral infarction, and hyperdense large vessel as occur in 
cases of MCA stroke. But these early signs of cerebral infarction have a poor conspicuity with 
a sensitivity that ranges between 56% and 81%118. Even trained observers reach only 
moderate interrater agreements119-121. Exclusion of hemorrhage and the early signs of 
ischemia are helpful for the decision upon further stroke management, especially when 
thrombolysis is concerned. Therefore important thrombolysis protocols as European 
Cooperative Acute Stroke Study (ECASS) and European and Australian Cooperative Acute 
Stroke Study II (ECASSS II) were based on CT evaluation rather than MRI. In later 
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progression, the changes of ischemia become more apparent on the noncontrast CT: edema, 
mass effect, and if happens, hemorrhagic transformation.   
The other two promising techniques are CT angiography and perfusion CT. CT angiography 
(CTA) is a 3-dimensional reconstruction of the cerebral vasculature from source images 
showing contrast material in the cerebral vessels shortly after an intravenous contrast bolus. It 
is a fairly sensitive technique in identifying large vessel occlusions122, 123. It can be also used 
to track patients, who have undergone recanalization procedures, with large vessel occlusions. 
A normal CTA can be used to exclude patients from further aggressive recanalization 
procedures. However, CTA is not able to define viable ischemic tissue that is likely to benefit 
from recanalization. CT perfusion, like the MRI based perfusion technique, works with a rapid 
intravenous injection of high volume contrast and is used to construct perfusion CT images. 
The perfusion deficit gives an estimate of the extent of microvasculature hypoperfusion and 
hypometabolism. Although it is validated for cerebral infarction124, 125, CT perfusion is not 
able to cover the entire brain and is limited to a few slices depending on the scanner used126, 
127. CT is much appreciated in a huge proportion of hospitals as basic stroke examination 
settings, since it is quick and reliable. 
Positron emission tomography (PET)  
In vivo measurements of metabolic rates in the brain have occupied the bulk of PET 
development over the last few decades. Helping to understand the biochemical basis for 
normal function and disease states, this in turn had vast basic research implications and some 
promising clinical applications. PET, mainly providing coupling between rCBF, regional 
cerebral metabolic rate for glucose (rCMRglc), and regional cerebral metabolic rate for 
oxygen (rCMRO2). In acute stage of ischemic stroke, both rCMRO2 decrease with a 
compensatory rise in regional oxygen extraction ration (rOER). At the same time, rCMRglc 
fall slightly128. SPECT is much less expensive and much less complex than PET, while it can 
do many of the same investigations. In cerebral infarction, SPECT of rCBF maps show 
changes between rCBF and metabolic demands changes which reflect the autoregulation129. 
When other methods introduced to measure physiological parameter in stroke, PET and 
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SPECT are always regarded as a standard130-134.  
 
Cerebral Angiography 
Cerebral angiography remains the gold standard for visualizing cerebrovascular anatomy. 
However, with the increasing availability and reliability of CTA and MRA, it is being used less 
often for purely diagnostic purposes and more often for possible interventions.  
In the hyperacute stroke setting, cerebral angiography is usually performed when intra-arterial 
thrombolysis treatment or mechanical interventions are planned. The objective of the initial 
part of an angiographic evaluation in patients with ischemic stroke is to document the site of the 
occlusion and the presence of collateralization to the affected area. In addition to occluded 
vessels, abnormal vascular filling patterns, such as slow anterograde flow with prolonged 
contrast stasis, retrograde filling through collateral channels, arteriovenous shunting, and 
vascular blush secondary to luxury perfusion, also aid in the characterization of cerebral 
infarction135. 
Ultrasonography 
Ultrasonographic investigations play an important role in identifying arterial narrowing and 
occlusion in the setting of cerebrovascular disease. B-mode images are built on the echo 
impulse principle and provide information about morphologic structures within the vascular 
lumen and the surrounding tissues. This mode imaging does not provide sufficient morphologic 
details to study deeply situated intracranial vessels. The Doppler technique can calculate blood 
flow velocities, and in turn arterial velocities are used to indirectly calculate the degree of 
stenosis in the vessel studied. Modern duplex machines combine the two techniques and are 
able to provide both morphologic and blood flow information136. 
In stroke, Transcranial Doppler (TCD) can demonstrate that the artery in the territory of the 
infarct is patent, or is early recanalised by embolus lysis, migration and fragmentation137. To 
noninvasively assess extracranial and intracranial vessel status Doppler ultrasound (DU) is 
regarde as the most widely available tool138, which is bedside available not only to ascertain 
baseline vessel status but also to monitor the process or absence of recanalization. 
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While it is well accepted that Doppler technique is reliable method for intracranial vessel 
morphology, the ultrasonic perfusion imaging using ultrasound echo contrast agents is still in 
an early stage. However, the potential of ultrasound perfusion technologies to compete with 
perfusion CT, perfusion MRI, and SPECT is evident139. It is also thought that the widely 
availability and cost-effectiveness of ultrasound machines makes ultrasonic perfusion imaging 
techniques a supplementary perfusion techniques in acute stroke diagnosis and monitoring140.   
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5 SUMMARY 
Introduction: Stroke is the third leading cause of death, and is the leading cause of 
disabilities worldwide. Although stroke may result from localized cerebral ischemia, 
intracerebral hemorrhage, subarachnoid hemorrhage or venous sinus thrombosis, ischemic 
stroke is the most frequently cause of the total cases. In ischemic stroke, occlusion of the 
MCA or its branches accounts for more than 3/4 of infarcts and two thirds of all first strokes. 
The main mechanisms causing ischemic strokes are embolism and arterial thromboembolism. 
No matter what the mechanism an ischemic stroke is, they eventually lead to a focal reduction 
of perfusion in the brain.  
In the hyperacute stage the recognition of the ischemia using both clinical assessment and 
routine neuroimaging technique implies some uncertainties, which in turn makes it difficult to 
predict the outcome, either to improve or to reverse spontaneously, to persist or worsen. The 
concept of diffusion/perfusion mismatch attracted great attention since it may represent the 
tissue at risk or at least an index of penumbra. Our interest was to investigate whether the 
hemodynamic parameters had correlation with clinical severity and if they were useful for 
prediction of outcome in the mismatch region. Since diffusion/perfusion mismatch was 
recognized as a simple and feasible means to identify the ischemic penumbra, we evaluated 
the hemodynamic parameters in acute stroke patients and compared these parameter to the 
stroke scale NIHSS and to the outcome score MRS to investigate our hypothesis. 
Materials and Methods: 35 acute stroke patients (male:female=20:15, age: 61.3±15.2 years) 
who met the study inclusion and exclusion criteria were selected. Significant cerebrovascular 
risk factors were recorded in 27 patients. The NIHSS assessment was immediately performed 
at the patients’ admission by a neurologist. Functional outcome was measured on the day of 
hospital discharge following MRS. Routine MRI sequences and DWI and PWI (dynamic 
susceptibility contrast-enhanced [DSC] imaging) were employed in our patients study. The 
perfusion maps were processed with MEDx® and the parameters were obtained by 
identifying ROIs on both ischemic core and mismatch region, and the normal mirror region. 
Relative values of the hemodynamic perfusion parameters were used in the evaluation. 
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Statistic treatment was used to test the significance of the result. 
Results: The NIHSS score ranged from 0 to 19 (10.2±4.4) and the outcome MRS scale ranged 
from 0 to 6 (mean: 3.23). Between the good outcome group (MRS 0 to 3) and the poor 
outcome group (MRS 4 to 6), time to scan, type of treatment, DW/PW volume ratio, and age 
and female/male ratio did not show significant differences.  
In ischemic core: rCBF showed a remarkable decrease in all patients on average by 59.3±
33.7% (range: 23.2 - 97.4%). rCBV decreased in 29 patients by 41.7±23.7% (range 19.6 - 
55.6%), while 6 patients showed an increase of rCBV by 60.4±57.1% (range 0.7 -139%). 
The mean rCBV change of the entire group was 26.3±52.5%. MTT, TTP and T0 prolonged 
for 4.7 (SD=15.1), 2.8 (SD=12.9) and 0.5 (SD=10.4) seconds, respectively. 
In mismatch region: rCBF decreased in 15 patients by 26.2±19.9% (range: 5.3-58.4%) and 
increased in 20 patients by 35±23.2% (range: 6.8–74.4%). The change of the rCBF of the 
whole patients group was 5.8±38.4%. rCBV decreased in 7 patients by 14.7±16.5% (range: 
0.8-44.5%) and increased in 28 patients by 39.5±36% (range: 2.2-91.1%). The mean change 
of the rCBV of the whole group was 19.9±31.2%. The mean value of MTT, TTP and T0 
prolonged for 2.7 (SD=8.5), 3.2 (SD=5.2) and 1.3 (SD=4.2) seconds respectively. 
In both core and mismatch region, rCBF showed statistically significant regression to MRS. 
The more the rCBF decreased the higher the MRS (poor outcome) was. Also, the MTT delay 
in the core region was significantly related to MRS. TTP delay, in both core and mismatch 
region, was related to both NIHSS and MRS significantly. No statistic significance was found 
comparing CBV and T0 in relation with NIHSS or MRS.  
Conclusion: The hemodynamic parameters derived from perfusion MR imaging may be 
helpful adjunct to predict the outcome and severity in acute stroke patients. In mismatch 
region, the rCBF and TTP are predictive for the stroke outcome.  
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ZUSAMMENFASSUNG 
Der zerebrale Schlaganfall stellt in den Industrienationen den dritthäufigste Todesursache dar, 
und ist die häufigste Ursache bei Behinderungen weltweit. Wenn auch zerebrale Schlaganfälle 
durch verschiedene Ursachen wie lokale zerebrale Ischämie, intrakraniale Blutung oder 
venöser Infarzierung entstehen, so ist der arterielle ischämische Schlaganfall der weitaus 
häufigste Grund. Von diesen Fällen sind wiederum etwa 3/4 der symptomatischen Fälle 
bedingt durch eine Verlegung der A. cerebri media oder ihrer Äste. Hier spielen die 
Embolisierung oder die Thrombose eine führende Rolle. Unabhängig von dem vorliegenden 
Pathomechanismus spielt die resultierende Perfusionsminderung des Parenchyms eine 
entscheidende Rolle.  
In der Akutphase eines Schlaganfalls ist häufig trotz der klinischen Untersuchung und der 
üblichen bildgebenden Diagnostik nur schwer abzuschätzen, ob die Prognose entsprechend 
einer günstigen Form verlaufen wird, oder ob der Patient klinisch stabil bleibt oder sich sogar 
im Verlauf weiter verschlechtert. Das Konzept des MRT-basierten 
„Diffusions-Perfusions-Mismatch“ hat hier großes Interesse geweckt, da es potentiell das 
bereits irreversibel geschädigte Gewebe im Zentrum des Infarkts (Core) von dem noch zu 
rettenden Gewebe (Penumbra) unterscheiden kann. Unser Interesse war es deshalb zu 
untersuchen, ob die hämodynamischen Parameter des Diffusions-Perfusions-Mismatchs 
beider Regionen zuverlässig sind für die Abschätzung der Prognose bei Patienten mit einem 
akuten Schlaganfall.  
Methodik: Nach Anwendung der Ein- und Ausschlusskriterien der Studie wurden 35 
Patienten mit einem akuten Schlaganfall selektiert. Risikofaktoren waren nachweisbar in 
27/35 Patienten. Die akute Untersuchung wurde von dem aufnehmenden Neurologen 
durchgeführt und nach dem National Institute of Health Stroke Scale (NIHSS) bewertet. Das 
funktionelle Outcome wurde am Tag der Entlassung durch Anwendung des Modified Ranking 
Scale (MRS) dokumentiert. Die MRT -Untersuchung beinhaltete T2- und T1-gewichteten 
Sequenzen, Diffusions-gewichtete Sequenzen (DWI), und eine dynamische, 
susceptibilitätsgewichtete Perfusionsmessung, während der eine maschinellen Bolusinjektion 
von 0.2 mmol/KG Gadolinium-Chelaten erfolgte. Die Nachverarbeitung dieses Datensatzes 
  
71
 
erfolgte mittels einem kommerziell erhältlichen Programm MedX® (Sensor Systems). Die 
Analyse von relativen Werten erfolgte mit Regions-of-interest (ROI).  
Ergebnisse: Der NIHSS Score variierte von 0 bis 19 (im Mittel 10.2 + 4.4) und der Outcome 
MRS variierte zwischen 0 und 6 (im Mittel 3,2). Zwischen der Gruppe mit einem guten 
Outcome (MRS 0- 3) und der Gruppe mit einem schlechten Outcome (MRS 4 bis 6) gab es 
keine signifikanten Unterschiede bezüglich Alter, Geschlecht, Zeit von Beginn der Symptome 
bis zum MRT, Behandlungsprotokoll, oder Diffusion/Perfusion Volumina.  
In dem ischämischen Kerngebiet (Core) war ein bemerkenswerter Abfall des rCBF zu 
verzeichnen (59.3% + 33.7%). rCBV nahm bei 29 Patienten ab (im Mittel um 41.7% + 
23.7%), während bei 6 Patienten ein Anstieg zu verzeichnen war; die mittlere Änderung des 
rCBV betrug 26.3% + 52.5%. die Parameter MTT, TTP und T0 verlängerten sich im 
ischämischen Kerngebiet um 4.7, 2.8 und 0.5 Sekunden.  
In der Zone, die ein Perfusionsdefizit aufwies, aber noch keine Diffusionsstörung (Mismatch 
Region) war ein Abfall von rCBF in 15 Patienten im Mittel um 26.2% + 19.9% und bei 20 
Patienten ein Anstieg von rCBF im Mittel um 35% + 23.2% zu verzeichnen (Durchschnitt der 
Gruppe 5.8% + 38.4%). rCBV zeigte ebenfalls ein heterogenes Verhalten mit einem Anstieg 
bei 7 Patienten und einem rCBV Abfall bei 28 Patienten mit einer mittlere Änderung von 
19.9%+ 31.2%. Die mittleren Werte von MTT, TTP und To verlängerten sich im Mittel um 
2.7, 3.2 und 1.3 Sekunden.  
In beiden Zonen (Zentrum und Mismatch) Region, zeigte rCBF eine statistisch signifikante 
Regression zum MRS. Je geringer das regionale rCBF, desto schlechter war das Outcome. 
Darüber hinaus fand sich eine signifikante Korrelation von MTT- Zeitverlängerung zu einem 
schlechteren MRS. Eine verzögerte TTP korrelierte mit NIHSS und MRS. Dagegen konnte 
bezüglich der Korrelation von rCBV und T0 keine Signifikanz festgestellt werden.  
Schlussfolgerung: Die hämodynamischen Parameter der Perfusions-MRT können eine gute 
Abschätzung der Prognose bei Patienten mit einer akuten Ischämie der MCA ermöglichen. 
Insbesondere rCBF und TTP zeigen eine signifikante Korrelation zum Modifed Ranking 
Scale bei Entlassung. 
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6 ABBREVIATIONS 
ACA anterior cerebral artery 
ADC apparent diffusion coefficient 
AIF Arterial input function 
CBF cerebral blood flow 
CBV cerebral blood volume 
CT computed tomography 
CTA computed tomography angiography 
DU Doppler ultrasound 
DWI diffusion weighted imaging 
EPI Echo-planar imaging 
FLAIR fast-fluid-attenuated inversion recovery 
FOV field of view 
ICA internal carotid artery 
MCA middle cerebral artery 
MRA magnetic resonance angiography 
MRI magnetic resonance imaging 
MRS Modified Rankin Scale 
MTT mean transit time 
NIHSS National Institute of Health Stroke Scale 
PCA Posterior cerebral artery 
PET Positron emission tomography  
PWI perfusion weighted imaging 
rCBF relative cerebral blood flow  
rCBV relative cerebral blood volume 
rrCBV relative regional cerebral blood volume 
rCMRglc regional cerebral metabolic rate for glucose 
rCMRO2 regional cerebral metabolic rate for oxygen 
RF radiofrequency 
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ROI Regions of interest 
SD standard deviation 
SPECT Single Photon Emission Computed Tomography 
T1WI T1 weighted imaging 
T2WI T2 weighted imaging 
TCD Transcranial Doppler 
TE Echo Time 
TR Repetition Time 
TTP time to peak 
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7 APPENDIX 
Appendix 1 
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